Paragon Care Limited Stock

Equities

PGC

AU000000PGC4

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 02:10:51 2024-04-24 am EDT 5-day change 1st Jan Change
0.34 AUD 0.00% Intraday chart for Paragon Care Limited +6.25% +51.11%
Sales 2024 * 325M 212M Sales 2025 * 348M 228M Capitalization 227M 148M
Net income 2024 * 10M 6.53M Net income 2025 * 14M 9.14M EV / Sales 2024 * 0.95 x
Net Debt 2024 * 82.4M 53.82M Net Debt 2025 * 69.8M 45.59M EV / Sales 2025 * 0.85 x
P/E ratio 2024 *
22.7 x
P/E ratio 2025 *
16.2 x
Employees 400
Yield 2024 *
-
Yield 2025 *
3.82%
Free-Float 61.21%
More Fundamentals * Assessed data
Dynamic Chart
1 week+6.25%
Current month+9.68%
1 month+19.30%
3 months+58.14%
6 months+94.29%
Current year+51.11%
More quotes
1 week
0.32
Extreme 0.32
0.34
1 month
0.28
Extreme 0.28
0.34
Current year
0.20
Extreme 0.2
0.34
1 year
0.15
Extreme 0.15
0.34
3 years
0.15
Extreme 0.15
0.49
5 years
0.10
Extreme 0.095
0.52
10 years
0.10
Extreme 0.095
0.97
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-02-15
Corporate Secretary - 22-08-14
Corporate Secretary 51 18-06-28
Members of the board TitleAgeSince
Chief Executive Officer - 22-02-15
Chairman 70 05-12-20
Director/Board Member - 16-06-02
More insiders
Date Price Change Volume
24-04-24 0.34 0.00% 1,847,245
24-04-23 0.34 0.00% 756,324
24-04-22 0.34 +4.62% 1,126,720
24-04-19 0.325 0.00% 191,902
24-04-18 0.325 +1.56% 195,192

Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT

More quotes
Paragon Care Limited is an Australia-based company. It is engaged in the supply of durable medical equipment, medical devices and consumable medical products and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia. Its segments include Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. Diagnostic and Scientific segment incorporates blood bank diagnostics manufacturer, clinical pathology diagnostics distribution and scientific and research and development (R&D) laboratory equipment distribution. Devices Segment incorporates ophthalmology and optometry, orthopedics, pain management, infection prevention and ortho biologics. Capital and Consumables segment includes medical, surgical and veterinary services. Service and Technology segment includes offering from biomedical devices to high end capital equipment, service support and technology management and service partnership with brands.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.34 AUD
Average target price
0.31 AUD
Spread / Average Target
-8.82%
Consensus